SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Ticker SymbolSINT
Company nameSINTX Technologies Inc
IPO dateFeb 11, 2014
CEOOlson (Eric K)
Number of employees20
Security typeOrdinary Share
Fiscal year-endFeb 11
Address1885 West 2100 Street
CitySALT LAKE CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84119
Phone18018393516
Websitehttps://sintx.com/
Ticker SymbolSINT
IPO dateFeb 11, 2014
CEOOlson (Eric K)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data